Development
Healwell AI Inc.
AIDX.TO
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -11.01% | -35.33% | -45.05% | -52.24% | -46.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.01% | -35.33% | -45.05% | -52.24% | -46.20% |
| Cost of Revenue | -8.01% | -36.09% | -47.01% | -53.72% | -47.81% |
| Gross Profit | -17.02% | -33.66% | -40.50% | -48.86% | -42.63% |
| SG&A Expenses | -12.74% | -32.24% | -42.86% | -44.79% | -22.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.65% | -26.64% | -33.39% | -37.03% | -27.71% |
| Operating Income | 5.71% | 12.07% | 9.19% | -3.06% | -26.20% |
| Income Before Tax | -53.76% | -39.60% | -7.31% | -6.97% | -31.53% |
| Income Tax Expenses | -185.79% | 220.18% | 236.44% | 250.44% | 201.50% |
| Earnings from Continuing Operations | -35.95% | -68.56% | -25.78% | -19.49% | -58.60% |
| Earnings from Discontinued Operations | 157.99% | 162.67% | -458.58% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.17% | 86.60% | 104.68% | 16.29% | -598.67% |
| Net Income | -21.10% | -49.77% | -31.08% | -29.76% | -73.08% |
| EBIT | 5.71% | 12.07% | 9.19% | -3.06% | -26.20% |
| EBITDA | -1.38% | 6.90% | -3.22% | -10.01% | -38.48% |
| EPS Basic | -14.46% | -44.22% | -28.17% | -26.17% | -61.42% |
| Normalized Basic EPS | 6.97% | 13.06% | 11.01% | -1.30% | -18.80% |
| EPS Diluted | -14.46% | -44.22% | -28.17% | -26.17% | -61.42% |
| Normalized Diluted EPS | 6.97% | 13.06% | 11.01% | -1.30% | -18.80% |
| Average Basic Shares Outstanding | 4.95% | 3.32% | 2.40% | 3.74% | 9.36% |
| Average Diluted Shares Outstanding | 4.95% | 3.32% | 2.40% | 3.74% | 9.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |